Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

CS MEDICA A/S: CS MEDICA: CANNASEN® is now a registered brand in Australia

CS MEDICA ("CS MEDICA" or the "Company") announces today that the Company has received certificates of registration for the trademark CANNASEN[®] in Australia. This marks a step for securing the brand in the Company's expansion on the global market.

CS MEDICA announces today that the trademark offices in Australia have approved CS MEDICA's trademark CANNASEN[®].

"One of the things to secure when building a global business is trademarks. CS MEDICA has always been active in filing patents to secure the future of our products, but we also see the value of securing our brands with trademark registration. This is an additional important step we are taking in our global sales strategy." says CEO Lone Henriksen.

The trademark approval of CANNASEN[®] is an important step in CS MEDICA's market strategy to expand sales of its product line CANNASEN[®] in the global market. The trademark registration no. for CANNASEN[®] in Australia is 2233150 and is valid until November 19, 2028.

Trademarks as of October 2023;[image]

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.